Fertile grounds in Asia for private equity investments in healthcare

THERE has never been a better time to raise money for Asian companies in the life sciences sector as the Covid-19 pandemic exposes cracks in the healthcare systems and distribution channels, forcing many in healthcare and insurance to seek innovative solutions.